Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Abiogen Pharma S.p.A.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Abiogen Pharma S.p.A
Italy Flag
Country
Country
Italy
Address
Address
Abiogen Pharma S.p.a. Via Meucci, n° 36 56121 Pisa - Loc. Ospedaletto
Telephone
Telephone
39 050 315 4101
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Through the acquisition, Abiogen gets Effrx's Binosto (alendronate sodium), an effervescent tablet for the treatment of osteoporosis. It will allow Abiogen to continue developing on Effrx's bisphosphonates family of molecules that in the area of ​​osteoarticular metabolism.


Lead Product(s): Alendronate Sodium

Therapeutic Area: Musculoskeletal Product Name: Binosto

Highest Development Status: ApprovedProduct Type: Small molecule

Recipient: EffRx Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition May 29, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY